LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article ; Online: Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a.

    Caus, Maite / Alonso-Montes, Cristina / Fernandez-Martin, Jose Luis / Marti-Antonio, Manuel / Bozic, Milica / Valdivielso, Jose M

    Arteriosclerosis, thrombosis, and vascular biology

    2023  Volume 43, Issue 8, Page(s) 1533–1548

    Abstract: Background: Vascular calcification (VC) is a highly prevalent complication of chronic kidney disease (CKD) and is associated with the higher morbidity-mortality of patients with CKD. VDR (vitamin D receptor) has been proposed to play a role in the ... ...

    Abstract Background: Vascular calcification (VC) is a highly prevalent complication of chronic kidney disease (CKD) and is associated with the higher morbidity-mortality of patients with CKD. VDR (vitamin D receptor) has been proposed to play a role in the osteoblastic differentiation of vascular smooth muscle cells (VSMCs), but the involvement of vitamin D in VC associated to CKD is controversial. Our aim was to determine the role of local vitamin D signaling in VSMCs during CKD-induced VC.
    Methods: We used epigastric arteries from CKD-affected patients and individuals with normal renal function, alongside an experimental model of CKD-induced VC in mice with conditional deletion of VDR in VSMC. In vitro, experiments in VSMC with or without VDR incubated in calcification media were also used.
    Results: CKD-affected patients and mice with CKD showed an increase in VC, together with increased arterial expression of VDR compared with controls with normal renal function. Conditional gene silencing of VDR in VSMCs led to a significant decrease of VC in the mouse model of CKD, despite similar levels of renal impairment and serum calcium and phosphate levels. This was accompanied by lower arterial expression of OPN (osteopontin) and lamin A and higher expression of SOST (sclerostin). Furthermore, CKD-affected mice showed a reduction of miR-145a expression in calcified arteries, which was significantly recovered in animals with deletion of VDR in VSMC. In vitro, the absence of VDR prevented VC, inhibited the increase of OPN, and reestablished the expression of miR-145a. Forced expression of miR-145a in vitro in VDR
    Conclusions: Our study provides evidence proving that inhibition of local VDR signaling in VSMCs could prevent VC in CKD and indicates a possible role for miR-145a in this process.
    MeSH term(s) Mice ; Animals ; Muscle, Smooth, Vascular/metabolism ; Receptors, Calcitriol/genetics ; Vascular Calcification/genetics ; Vascular Calcification/prevention & control ; Kidney/metabolism ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/genetics ; Renal Insufficiency, Chronic/metabolism ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Vitamin D/metabolism ; Myocytes, Smooth Muscle/metabolism
    Chemical Substances Receptors, Calcitriol ; MicroRNAs ; Vitamin D (1406-16-2)
    Language English
    Publishing date 2023-06-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.122.318834
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.

    Martín-Vírgala, Julia / Martín-Carro, Beatriz / Fernández-Villabrille, Sara / Ruiz-Torres, María Piedad / Gómez-Alonso, Carlos / Rodríguez-García, Minerva / Fernández-Martín, José Luis / Alonso-Montes, Cristina / Panizo, Sara / Cannata-Andía, Jorge B / Naves-Díaz, Manuel / Carrillo-López, Natalia

    International journal of molecular sciences

    2024  Volume 25, Issue 3

    Abstract: Shortly after the discovery of Klotho, interest grew in its potential role in chronic kidney disease (CKD). There are three isoforms of the Klotho protein: αKlotho, βKlotho and γKlotho. This review will focus on αKlotho due to its relevance as a ... ...

    Abstract Shortly after the discovery of Klotho, interest grew in its potential role in chronic kidney disease (CKD). There are three isoforms of the Klotho protein: αKlotho, βKlotho and γKlotho. This review will focus on αKlotho due to its relevance as a biomarker in CKD. αKlotho is synthesized mainly in the kidneys, but it can be released into the bloodstream and urine as soluble Klotho (sKlotho), which undertakes systemic actions, independently or in combination with FGF23. It is usually accepted that sKlotho levels are reduced early in CKD and that lower levels of sKlotho might be associated with the main chronic kidney disease-mineral bone disorders (CKD-MBDs): cardiovascular and bone disease. However, as results are inconsistent, the applicability of sKlotho as a CKD-MBD biomarker is still a matter of controversy. Much of the inconsistency can be explained due to low sample numbers, the low quality of clinical studies, the lack of standardized assays to assess sKlotho and a lack of consensus on sample processing, especially in urine. In recent decades, because of our longer life expectancies, the prevalence of accelerated-ageing diseases, such as CKD, has increased. Exercise, social interaction and caloric restriction are considered key factors for healthy ageing. While exercise and social interaction seem to be related to higher serum sKlotho levels, it is not clear whether serum sKlotho might be influenced by caloric restriction. This review focuses on the possible role of sKlotho as a biomarker in CKD-MBD, highlighting the difference between solid knowledge and areas requiring further research, including the role of sKlotho in healthy ageing.
    MeSH term(s) Humans ; Biomarkers ; Chronic Kidney Disease-Mineral and Bone Disorder/diagnosis ; Fibroblast Growth Factors ; Glucuronidase ; Healthy Aging/metabolism ; Minerals ; Renal Insufficiency, Chronic/complications ; Klotho Proteins/blood ; Klotho Proteins/metabolism
    Chemical Substances Biomarkers ; Fibroblast Growth Factors (62031-54-3) ; Glucuronidase (EC 3.2.1.31) ; Minerals ; Klotho Proteins (EC 3.2.1.31)
    Language English
    Publishing date 2024-02-03
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms25031843
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Novel Biomarkers of Bone Metabolism.

    Fernández-Villabrille, Sara / Martín-Carro, Beatriz / Martín-Vírgala, Julia / Rodríguez-Santamaria, Mª Del Mar / Baena-Huerta, Francisco / Muñoz-Castañeda, Juan Rafael / Fernández-Martín, José Luis / Alonso-Montes, Cristina / Naves-Díaz, Manuel / Carrillo-López, Natalia / Panizo, Sara

    Nutrients

    2024  Volume 16, Issue 5

    Abstract: Bone represents a metabolically active tissue subject to continuous remodeling orchestrated by the dynamic interplay between osteoblasts and osteoclasts. These cellular processes are modulated by a complex interplay of biochemical and mechanical factors, ...

    Abstract Bone represents a metabolically active tissue subject to continuous remodeling orchestrated by the dynamic interplay between osteoblasts and osteoclasts. These cellular processes are modulated by a complex interplay of biochemical and mechanical factors, which are instrumental in assessing bone remodeling. This comprehensive evaluation aids in detecting disorders arising from imbalances between bone formation and reabsorption. Osteoporosis, characterized by a reduction in bone mass and strength leading to heightened bone fragility and susceptibility to fractures, is one of the more prevalent chronic diseases. Some epidemiological studies, especially in patients with chronic kidney disease (CKD), have identified an association between osteoporosis and vascular calcification. Notably, low bone mineral density has been linked to an increased incidence of aortic calcification, with shared molecules, mechanisms, and pathways between the two processes. Certain molecules emerging from these shared pathways can serve as biomarkers for bone and mineral metabolism. Detecting and evaluating these alterations early is crucial, requiring the identification of biomarkers that are reliable for early intervention. While traditional biomarkers for bone remodeling and vascular calcification exist, they suffer from limitations such as low specificity, low sensitivity, and conflicting results across studies. In response, efforts are underway to explore new, more specific biomarkers that can detect alterations at earlier stages. The aim of this review is to comprehensively examine some of the emerging biomarkers in mineral metabolism and their correlation with bone mineral density, fracture risk, and vascular calcification as well as their potential use in clinical practice.
    MeSH term(s) Humans ; Chronic Kidney Disease-Mineral and Bone Disorder/complications ; Osteoporosis/etiology ; Bone Density/physiology ; Renal Insufficiency, Chronic/complications ; Fractures, Bone/etiology ; Vascular Calcification/complications ; Biomarkers ; Minerals
    Chemical Substances Biomarkers ; Minerals
    Language English
    Publishing date 2024-02-22
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu16050605
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure.

    Martínez-Arias, Laura / Fernández-Villabrille, Sara / Alonso-Montes, Cristina / García-Navazo, Gonzalo / Ruíz-Torres, María P / Alajarín, Ramón / Alvarez-Builla, Julio / Gutiérrez-Calabres, Elena / Vaquero-López, Juan José / Carrillo-López, Natalia / Rodríguez-Puyol, Diego / Cannata-Andía, Jorge B / Panizo, Sara / Naves-Díaz, Manuel

    Nutrients

    2023  Volume 15, Issue 8

    Abstract: Drugs providing antihypertensive and protective cardiovascular actions are of clinical interest in controlling cardiovascular events and slowing the progression of kidney disease. We studied the effect of a hybrid compound, GGN1231 (derived from losartan ...

    Abstract Drugs providing antihypertensive and protective cardiovascular actions are of clinical interest in controlling cardiovascular events and slowing the progression of kidney disease. We studied the effect of a hybrid compound, GGN1231 (derived from losartan in which a powerful antioxidant was attached), on the prevention of cardiovascular damage, cardiac hypertrophy, and fibrosis in a rat model of severe chronic renal failure (CRF). CRF by a 7/8 nephrectomy was carried out in male Wistar rats fed with a diet rich in phosphorous (0.9%) and normal calcium (0.6%) for a period of 12 weeks until sacrifice. In week 8, rats were randomized in five groups receiving different drugs including dihydrocaffeic acid as antioxidant (Aox), losartan (Los), dihydrocaffeic acid+losartan (Aox+Los) and GGN1231 as follows: Group 1 (CRF+vehicle group), Group 2 (CRF+Aox group), Group 3 (CRF+Los group), Group 4 (CRF+Aox+Los group), and Group 5 (CRF+GGN1231 group). Group 5, the CRF+GGN1231 group, displayed reduced proteinuria, aortic TNF-α, blood pressure, LV wall thickness, diameter of the cardiomyocytes, ATR1, cardiac TNF-α and fibrosis, cardiac collagen I, and TGF-β1 expression. A non-significant 20% reduction in the mortality was also observed. This study showed the possible advantages of GGN1231, which could help in the management of cardiovascular and inflammatory processes. Further research is needed to confirm and even expand the positive aspects of this compound.
    MeSH term(s) Rats ; Male ; Animals ; Losartan/pharmacology ; Losartan/therapeutic use ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Tumor Necrosis Factor-alpha/pharmacology ; Rats, Wistar ; Kidney Failure, Chronic ; Models, Theoretical ; Fibrosis ; Kidney/metabolism
    Chemical Substances Losartan (JMS50MPO89) ; 3,4-dihydroxyphenylpropionic acid (1078-61-1) ; Antioxidants ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2023-04-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15081820
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities.

    Martín-Carro, Beatriz / Donate-Correa, Javier / Fernández-Villabrille, Sara / Martín-Vírgala, Julia / Panizo, Sara / Carrillo-López, Natalia / Martínez-Arias, Laura / Navarro-González, Juan F / Naves-Díaz, Manuel / Fernández-Martín, José L / Alonso-Montes, Cristina / Cannata-Andía, Jorge B

    International journal of molecular sciences

    2023  Volume 24, Issue 12

    Abstract: Preclinical biomedical models are a fundamental tool to improve the knowledge and management of diseases, particularly in diabetes mellitus (DM) since, currently, the pathophysiological and molecular mechanisms involved in its development are not fully ... ...

    Abstract Preclinical biomedical models are a fundamental tool to improve the knowledge and management of diseases, particularly in diabetes mellitus (DM) since, currently, the pathophysiological and molecular mechanisms involved in its development are not fully clarified, and there is no treatment to cure DM. This review will focus on the features, advantages and limitations of some of the most used DM models in rats, such as the spontaneous models: Bio-Breeding Diabetes-Prone (BB-DP) and LEW.1AR1-
    MeSH term(s) Humans ; Rats ; Animals ; Disease Models, Animal ; Streptozocin ; Rats, Zucker ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 2/complications
    Chemical Substances Streptozocin (5W494URQ81)
    Language English
    Publishing date 2023-06-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms241210309
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification.

    Fernández-Villabrille, Sara / Martín-Carro, Beatriz / Martín-Vírgala, Julia / Alonso-Montes, Cristina / Palomo-Antequera, Carmen / García-Castro, Raúl / López-Ongil, Susana / Dusso, Adriana S / Fernández-Martín, José Luis / Naves-Díaz, Manuel / Cannata-Andía, Jorge B / Carrillo-López, Natalia / Panizo, Sara

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2023  Volume 38, Issue 7, Page(s) 1729–1740

    Abstract: Introduction: MicroRNAs (miRs) regulate vascular calcification (VC), and their quantification may contribute to suspicion of the presence of VC.: Methods: The study was performed in four phases. Phase 1: miRs sequencing of rat calcified and non- ... ...

    Abstract Introduction: MicroRNAs (miRs) regulate vascular calcification (VC), and their quantification may contribute to suspicion of the presence of VC.
    Methods: The study was performed in four phases. Phase 1: miRs sequencing of rat calcified and non-calcified aortas. Phase 2: miRs with the highest rate of change, plus miR-145 [the most abundant miR in vascular smooth muscle cells (VSMCs)], were validated in aortas and serum from rats with and without VC. Phase 3: the selected miRs were analyzed in epigastric arteries from kidney donors and recipients, and serum samples from general population. Phase 4: VSMCs were exposed to different phosphorus concentrations, and miR-145 and miR-486 were overexpressed to investigate their role in VC.
    Results: miR-145, miR-122-5p, miR-486 and miR-598-3p decreased in the rat calcified aortas, but only miR-145 and miR-486 were detected in serum. In human epigastric arteries, miR-145 and miR-486 were lower in kidney transplant recipients compared with donors. Both miRs inversely correlated with arterial calcium content and with VC (Kauppila index). In the general population, the severe VC was associated with the lowest serum levels of both miRs. The receiver operating characteristic curve showed that serum miR-145 was a good biomarker of VC. In VSMCs exposed to high phosphorus, calcium content, osteogenic markers (Runx2 and Osterix) increased, and the contractile marker (α-actin), miR-145 and miR-486 decreased. Overexpression of miR-145, and to a lesser extent miR-486, prevented the increase in calcium content induced by high phosphorus, the osteogenic differentiation and the loss of the contractile phenotype.
    Conclusion: miR-145 and miR-486 regulate the osteogenic differentiation of VSMCs, and their quantification in serum could serve as a marker of VC.
    MeSH term(s) Animals ; Humans ; Rats ; Biomarkers ; Calcium ; MicroRNAs/genetics ; Muscle, Smooth, Vascular ; Myocytes, Smooth Muscle ; Osteogenesis/genetics ; Phosphorus ; Vascular Calcification/genetics
    Chemical Substances Biomarkers ; Calcium (SY7Q814VUP) ; MicroRNAs ; MIRN-598 microRNA, human ; MIRN145 microRNA, human ; MIRN145 microRNA, rat ; MIRN486 microRNA, human ; Phosphorus (27YLU75U4W)
    Language English
    Publishing date 2023-01-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfad027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145.

    Fernández-Villabrille, Sara / Martín-Carro, Beatriz / Martín-Vírgala, Julia / Alonso-Montes, Cristina / Fernández-Fernández, Alejandra / Martínez-Salgado, Carlos / Fernández-Martín, José L / Naves-Díaz, Manuel / Cannata-Andía, Jorge B / Carrillo-López, Natalia / Panizo, Sara

    Nutrients

    2023  Volume 15, Issue 13

    Abstract: Phosphorus is a vital element for life found in most foods as a natural component, but it is also one of the most used preservatives added during food processing. High serum phosphorus contributes to develop vascular calcification in chronic kidney ... ...

    Abstract Phosphorus is a vital element for life found in most foods as a natural component, but it is also one of the most used preservatives added during food processing. High serum phosphorus contributes to develop vascular calcification in chronic kidney disease; however, it is not clear its effect in a population without kidney damage. The objective of this in vivo and in vitro study was to investigate the effect of high phosphorus exposure on the aortic and serum levels of miR-145 and its effect on vascular smooth muscle cell (VSMCs) changes towards less contractile phenotypes. The study was performed in aortas and serum from rats fed standard and high-phosphorus diets, and in VSMCs exposed to different concentrations of phosphorus. In addition, miR-145 silencing and overexpression experiments were carried out. In vivo results showed that in rats with normal renal function fed a high P diet, a significant increase in serum phosphorus was observed which was associated to a significant decrease in the aortic α-actin expression which paralleled the decrease in aortic and serum miR-145 levels, with no changes in the osteogenic markers. In vitro results using VSMCs corroborated the in vivo findings. High phosphorus first reduced miR-145, and afterwards α-actin expression. The miR-145 overexpression significantly increased α-actin expression and partially prevented the increase in calcium content. These results suggest that miR-145 could be an early biomarker of vascular calcification, which could give information about the initiation of the transdifferentiation process in VSMCs.
    MeSH term(s) Rats ; Animals ; Phosphorus/metabolism ; Muscle, Smooth, Vascular ; Actins/metabolism ; Cell Transdifferentiation ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Phenotype ; Vascular Calcification/genetics ; Vascular Calcification/metabolism ; Myocytes, Smooth Muscle ; Cells, Cultured
    Chemical Substances Phosphorus (27YLU75U4W) ; Actins ; MicroRNAs ; MIRN145 microRNA, rat
    Language English
    Publishing date 2023-06-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15132918
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.

    Martín-Vírgala, Julia / Fernández-Villabrille, Sara / Martín-Carro, Beatriz / Tamargo-Gómez, Isaac / Navarro-González, Juan F / Mora-Fernández, Carmen / Calleros, Laura / Astudillo-Cortés, Elena / Avello-Llano, Noelia / Mariño, Guillermo / Dusso, Adriana S / Alonso-Montes, Cristina / Panizo, Sara / Cannata-Andía, Jorge B / Naves-Díaz, Manuel / Carrillo-López, Natalia

    Nutrients

    2023  Volume 15, Issue 6

    Abstract: This study was designed to investigate the controversy on the potential role of sKlotho as an early biomarker in Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD), to assess whether sKlotho is a reliable marker of kidney α-Klotho, to deepen the ... ...

    Abstract This study was designed to investigate the controversy on the potential role of sKlotho as an early biomarker in Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD), to assess whether sKlotho is a reliable marker of kidney α-Klotho, to deepen the effects of sKlotho on vascular smooth muscle cells (VSMCs) osteogenic differentiation and to evaluate the role of autophagy in this process. Experimental studies were conducted in CKD mice fed a normal phosphorus (CKD+NP) or high phosphorus (CKD+HP) diet for 14 weeks. The patients' study was performed in CKD stages 2-5 and in vitro studies which used VSMCs exposed to non-calcifying medium or calcifying medium with or without sKlotho. The CKD experimental model showed that the CKD+HP group reached the highest serum PTH, P and FGF23 levels, but the lowest serum and urinary sKlotho levels. In addition, a positive correlation between serum sKlotho and kidney α-Klotho was found. CKD mice showed aortic osteogenic differentiation, together with increased autophagy. The human CKD study showed that the decline in serum sKlotho is previous to the rise in FGF23. In addition, both serum sKlotho and FGF23 levels correlated with kidney function. Finally, in VSMCs, the addition of sKlotho prevented osteogenic differentiation and induced autophagy. It can be concluded that serum sKlotho was the earliest CKD-MBD biomarker, a reliable indicator of kidney α-Klotho and that might protect against osteogenic differentiation by increasing autophagy. Nevertheless, further studies are needed to investigate the mechanisms of this possible protective effect.
    MeSH term(s) Humans ; Mice ; Animals ; Klotho Proteins ; Glucuronidase ; Chronic Kidney Disease-Mineral and Bone Disorder ; Osteogenesis ; Fibroblast Growth Factors ; Kidney ; Renal Insufficiency, Chronic ; Phosphorus ; Minerals ; Biomarkers
    Chemical Substances Klotho Proteins (EC 3.2.1.31) ; Glucuronidase (EC 3.2.1.31) ; Fibroblast Growth Factors (62031-54-3) ; Phosphorus (27YLU75U4W) ; Minerals ; Biomarkers
    Language English
    Publishing date 2023-03-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15061470
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Redox Metabolism and Vascular Calcification in Chronic Kidney Disease.

    Carrillo-López, Natalia / Panizo, Sara / Martín-Carro, Beatriz / Mayo Barrallo, Juan Carlos / Román-García, Pablo / García-Castro, Raúl / Fernández-Gómez, Jesús María / Hevia-Suárez, Miguel Ángel / Martín-Vírgala, Julia / Fernández-Villabrille, Sara / Martínez-Arias, Laura / Vázquez, Sara Barrio / Calleros Basilio, Laura / Naves-Díaz, Manuel / Cannata-Andía, Jorge Benito / Quirós-González, Isabel / Alonso-Montes, Cristina / Fernández-Martín, José Luis

    Biomolecules

    2023  Volume 13, Issue 9

    Abstract: Vascular calcification (VC) is a common complication in patients with chronic kidney disease which increases their mortality. Although oxidative stress is involved in the onset and progression of this disorder, the specific role of some of the main redox ...

    Abstract Vascular calcification (VC) is a common complication in patients with chronic kidney disease which increases their mortality. Although oxidative stress is involved in the onset and progression of this disorder, the specific role of some of the main redox regulators, such as catalase, the main scavenger of H
    MeSH term(s) Humans ; Animals ; Rats ; Catalase ; Core Binding Factor Alpha 1 Subunit/genetics ; Hydrogen Peroxide ; Oxidation-Reduction ; Vascular Calcification ; Renal Insufficiency, Chronic
    Chemical Substances Catalase (EC 1.11.1.6) ; Core Binding Factor Alpha 1 Subunit ; Hydrogen Peroxide (BBX060AN9V)
    Language English
    Publishing date 2023-09-20
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2701262-1
    ISSN 2218-273X ; 2218-273X
    ISSN (online) 2218-273X
    ISSN 2218-273X
    DOI 10.3390/biom13091419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes.

    Martín-Carro, Beatriz / Martín-Vírgala, Julia / Fernández-Villabrille, Sara / Fernández-Fernández, Alejandra / Pérez-Basterrechea, Marcos / Navarro-González, Juan F / Donate-Correa, Javier / Mora-Fernández, Carmen / Dusso, Adriana S / Carrillo-López, Natalia / Panizo, Sara / Naves-Díaz, Manuel / Fernández-Martín, José L / Cannata-Andía, Jorge B / Alonso-Montes, Cristina

    International journal of molecular sciences

    2023  Volume 24, Issue 6

    Abstract: Fibrosis plays an important role in the pathogenesis of long-term diabetic complications and contributes to the development of cardiac and renal dysfunction. The aim of this experimental study, performed in a long-term rat model, which resembles type 1 ... ...

    Abstract Fibrosis plays an important role in the pathogenesis of long-term diabetic complications and contributes to the development of cardiac and renal dysfunction. The aim of this experimental study, performed in a long-term rat model, which resembles type 1 diabetes mellitus, was to investigate the role of soluble Klotho (sKlotho), advanced glycation end products (AGEs)/receptor for AGEs (RAGE), fibrotic Wnt/β-catenin pathway, and pro-fibrotic pathways in kidney and heart. Diabetes was induced by streptozotocin. Glycaemia was maintained by insulin administration for 24 weeks. Serum and urine sKlotho, AGEs, soluble RAGE (sRAGE) and biochemical markers were studied. The levels of Klotho, RAGEs, ADAM10, markers of fibrosis (collagen deposition, fibronectin, TGF-β1, and Wnt/β-catenin pathway), hypertrophy of the kidney and/or heart were analysed. At the end of study, diabetic rats showed higher levels of urinary sKlotho, AGEs and sRAGE and lower serum sKlotho compared with controls without differences in the renal Klotho expression. A significant positive correlation was found between urinary sKlotho and AGEs and urinary albumin/creatinine ratio (uACR). Fibrosis and RAGE levels were significantly higher in the heart without differences in the kidney of diabetic rats compared to controls. The results also suggest the increase in sKlotho and sRAGE excretion may be due to polyuria in the diabetic rats.
    MeSH term(s) Rats ; Animals ; Diabetes Mellitus, Experimental ; beta Catenin ; Kidney Diseases ; Receptor for Advanced Glycation End Products ; Fibrosis ; Glycation End Products, Advanced
    Chemical Substances beta Catenin ; Receptor for Advanced Glycation End Products ; Glycation End Products, Advanced
    Language English
    Publishing date 2023-03-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24065241
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top